Page last updated: 2024-08-17

nad and niraparib

nad has been researched along with niraparib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Estes, VM; Langelier, MF; Lee, BJ; Lin, X; Pascal, JM; Rouleau-Turcotte, É; Shao, Z; Zha, S1

Other Studies

1 other study(ies) available for nad and niraparib

ArticleYear
Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
    Nucleic acids research, 2020, 09-25, Volume: 48, Issue:17

    Topics: Binding Sites; Catalytic Domain; Cell Line, Tumor; DNA Damage; DNA Repair; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; Humans; Indazoles; Kinetics; Molecular Imaging; NAD; Piperidines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Recombinant Proteins; X-ray Repair Cross Complementing Protein 1

2020